surmount 1 tirzepatide SURMOUNT-1: Provides Significant, Sustained Weight Loss in Obesity SURMOUNT Clinical Trials Orals Session

Ideal for people who are sensitive to make-up, active in sports, or dont have time to apply make-up daily

Safety and efficacy of venglustat in GBA1-associated Parkinsons disease: an international, multicentre, double-blind, randomised, placebo-controlled, phase 2 trial

LEADER compared liraglutide to placebo in 9340 patients with T2DM and known CV disease or CV risk factors only [16]

This suggests tirzepatide has direct anti-inflammatory effects that operate independently of its metabolic benefits, at least in the initial weeks of treatment

Anticipated Dosing Framework Once-weekly injection: Consistent with other GLP-1 and GIP agonists, Retatrutide is expected to remain a weekly subcutaneous shot

This can help stabilise blood sugar levels and reduce the risk of developing type 2 diabetes